WALTHAM, Mass.--(BUSINESS WIRE)--Dec 5, 2024--
Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, released its fourth annual TGaS Digital Marketing Competency Report assessing the digital marketing presence for patients across 150+ biopharma brands. The study evaluates the brands across five categories and more than 100 characteristics to establish a brand digital competency ranking.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205305270/en/
Brands that topped the 2024 Digital Marketing Competency Report’s list include:
The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It examines time in market, therapeutic areas and impact on individual channels to give organizations unrivaled insight into how they can optimize their digital marketing execution. The study provides a comparison of biopharma brands to a sample of consumer brands outside of the pharmaceutical industry. This cross-industry perspective enables biopharma brands to identify where they lag and how they can enhance their digital and customer engagement strategies.
“The digital space is evolving at a faster pace than ever before, with more brands integrating digital-first strategies to better connect with patients and caregivers,” said Jerry Luciano, VP of Omnichannel Marketing, at TGaS Advisors, a Division of Trinity Life Sciences. “Over the past four years of conducting the study, we have observed an acceleration across the industry in driving an improved customer experience through digital.”
To download the summary of the report with the ranking of all 150+ brands, please visit TrinityLifeSciences.com or click here. The full report, including in-depth channel analysis and trends, is available to members of the TGaS Omnichannel Marketing network.
About Trinity Life Sciences
With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 350 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. We have a diverse staff of over 1200 people and 11 global offices across the U.S., Europe and Asia. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.
Cover image from Trinity Life Sciences’ fourth annual TGaS Digital Marketing Competency Report. (Photo: Business Wire)
NEW YORK (AP) — Gael Monfils stood in the middle of the court and bowed to the crowd that was treating the Frenchman to a roaring ovation on his 40th birthday.
The match was still a ways from ending. But after leaping in the air to smash a forehand winner — a daredevil shot that few outside one of tennis' ultimate showmen might even attempt — there was no reason to wait.
Monfils turned back the clock and pushed back the end of his Grand Slam career, beating Adolfo Daniel Vallejo 2-6, 6-1, 6-2, 6-0 on Tuesday night at the U.S. Open.
Monfils became the oldest man to win a U.S. Open match since Jimmy Connors — another guy who loved to put on a show in New York — defeated Jaime Oncins on Sept. 2, 1992, when he turned 40.
“That was definitely very special. To play the day of my 40th birthday is special. You guys made it, like, incredible,” Monfils said to the fans at Louis Armstrong Stadium, who then sang happy birthday to him.
Monfils is planning to retire after this year and is making a few more memories along the way at the tournament where he reached the 2016 semifinals. He began the event by teaming up with his wife, Elina Svitolina, to reach the mixed doubles semifinals in their first time competing together.
Then, before the singles play began, he looked ahead toward his looming birthday.
“I hit my 40th birthday the day I play, so this is a big milestone for me, able to play at 40,” Monfils said. “I want to do, not good but really good, for where I am now.”
He did amazing.
He quickly began to outplay Vallejo after dropping the first set, then really poured it on to begin the fourth. It was 1-0 when he hit his leaping forehand winner, then raised his hand toward his ear and spun it to encourage cheers that were already well underway.
Monfils acknowledged the obvious: Jumping to hit the shot is more difficult than just hitting a regular forehand. But with a comfortable lead at the time, he thought it would provide “more happiness, more joy for me.”
"You know, I tried it. Lucky I put it in, but somehow, I’m here to also enjoy myself. There’s not many, many times (left), and, you know, it was the right moment, so why not try it?”
Monfils, in his 18th U.S. Open appearance, earned his first Grand Slam win since the first round of Wimbledon in 2025. He advanced to face American Learner Tien, the No. 14 seed.
See AP’s full tennis coverage here
Gael Monfils, of France, celebrates after defeating Adolfo Daniel Vallejo, of Paraguay, during the first round of the U.S. Open tennis championships Tuesday, Sept. 1, 2026, in New York. (AP Photo/Adam Hunger)
Gael Monfils, of France, celebrates after defeating Adolfo Daniel Vallejo, of Paraguay, during the first round of the U.S. Open tennis championships Tuesday, Sept. 1, 2026, in New York. (AP Photo/Adam Hunger)
Gael Monfils, of France, celebrates after defeating Adolfo Daniel Vallejo, of Paraguay, during the first round of the U.S. Open tennis championships Tuesday, Sept. 1, 2026, in New York. (AP Photo/Adam Hunger)
Gael Monfils, of France, takes a bow after winning a point against Adolfo Daniel Vallejo, of Paraguay, during the first round of the U.S. Open tennis championships Tuesday, Sept. 1, 2026, in New York. (AP Photo/Adam Hunger)
